These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35665631)

  • 1. Synthesis, virtual screening and computational approach of a quinoxaline derivative as potent anti-HIV agent targeting the reverse transcriptase enzyme.
    El Bakri Y; Saravanan K; Ahmad S; Mague JT
    J Biomol Struct Dyn; 2023 Jul; 41(11):5277-5290. PubMed ID: 35665631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of quinoxaline compounds as anti-HIV agents targeting reverse transcriptase enzyme.
    Fabian L; Taverna Porro M; Gómez N; Salvatori M; Turk G; Estrin D; Moglioni A
    Eur J Med Chem; 2020 Feb; 188():111987. PubMed ID: 31893549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the protonation state in the interaction of an HIV-1 reverse transcriptase (RT) amino acid, Lys101, and a non nucleoside RT inhibitor, GW420867X.
    Galembeck SE; Bickelhaupt FM; Fonseca Guerra C; Galembeck E
    J Mol Model; 2014 Jul; 20(7):2332. PubMed ID: 24965933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An
    da Costa APL; Cardoso FJB; Molfetta FA
    J Biomol Struct Dyn; 2023 Mar; 41(5):1715-1729. PubMed ID: 34996334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of new Reissert analogs as HIV-1 reverse transcriptase inhibitors. 1. Quinoline and quinoxaline derivatives.
    Font M; Monge A; Alvarez E; Cuartero A; Losa MJ; Fidalgo MJ; SanMartín C; Nadal E; Ruiz I; Merino I; Martínez-Irujo JJ; Alberdi E; Santiago E; Prieto I; Lasarte JJ; Sarobe P; Borrás F
    Drug Des Discov; 1997 Apr; 14(4):305-32. PubMed ID: 9197981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of N4-(hetero)arylsulfonylquinoxalinones as HIV-1 reverse transcriptase inhibitors.
    Xu B; Sun Y; Guo Y; Cao Y; Yu T
    Bioorg Med Chem; 2009 Apr; 17(7):2767-74. PubMed ID: 19269831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HIV/SIV activity of icariin and its metabolite anhydroicaritin mainly involve reverse transcriptase.
    Xie Y; Xie L; Chen A; Wu S; Mo Y; Guo X; Zeng C; Huang X; He J
    Eur J Pharmacol; 2020 Oct; 884():173327. PubMed ID: 32726656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel theoretically designed HIV-1 non-nucleoside reverse transcriptase inhibitors derived from nevirapine.
    Liu J; He X; Zhang JZ
    J Mol Model; 2014 Oct; 20(10):2451. PubMed ID: 25234608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking-based 3D-QSAR analyses of pyrazole derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Cichero E; Fossa P
    J Mol Model; 2012 Apr; 18(4):1573-82. PubMed ID: 21805124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the crystal structure of two newly synthesized quinoxalines derivatives as potent inhibitor for
    Abad N; El Bakri Y; Lai CH; Karthikeyan S; Ramli Y; Ferfra S; Mague JT; Essassi EM
    J Biomol Struct Dyn; 2022 Apr; 40(6):2797-2814. PubMed ID: 33200685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors.
    Gawali R; Trivedi J; Bhansali S; Bhosale R; Sarkar D; Mitra D
    Eur J Med Chem; 2018 Sep; 157():310-319. PubMed ID: 30099253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Docking Studies of HIV-1 Resistance to Reverse Transcriptase Inhibitors: Mini-Review.
    Tarasova O; Poroikov V; Veselovsky A
    Molecules; 2018 May; 23(5):. PubMed ID: 29883406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 Reverse Transcriptase Dimerization by Small Molecules.
    Tintori C; Corona A; Esposito F; Brai A; Grandi N; Ceresola ER; Clementi M; Canducci F; Tramontano E; Botta M
    Chembiochem; 2016 Apr; 17(8):683-8. PubMed ID: 26946324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 gp120 Antagonists Also Inhibit HIV-1 Reverse Transcriptase by Bridging the NNRTI and NRTI Sites.
    Losada N; Ruiz FX; Curreli F; Gruber K; Pilch A; Das K; Debnath AK; Arnold E
    J Med Chem; 2021 Nov; 64(22):16530-16540. PubMed ID: 34735153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of dihydroquinazoline-2-amines as potent non-nucleoside reverse transcriptase inhibitors of wild-type and mutant HIV-1 strains.
    Jin K; Sang Y; Han S; De Clercq E; Pannecouque C; Meng G; Chen F
    Eur J Med Chem; 2019 Aug; 176():11-20. PubMed ID: 31091477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
    Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico screening for non-nucleoside HIV-1 reverse transcriptase inhibitors using physicochemical filters and high-throughput docking followed by in vitro evaluation.
    Bustanji Y; Al-Masri IM; Qasem A; Al-Bakri AG; Taha MO
    Chem Biol Drug Des; 2009 Sep; 74(3):258-65. PubMed ID: 19703027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory Effect of 2,3,5,6-Tetrafluoro-4-[4-(aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide Derivatives on HIV Reverse Transcriptase Associated RNase H Activities.
    Pala N; Esposito F; Rogolino D; Carcelli M; Sanna V; Palomba M; Naesens L; Corona A; Grandi N; Tramontano E; Sechi M
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Looking for an active conformation of the future HIV type-1 non-nucleoside reverse transcriptase inhibitors.
    La Regina G; Coluccia A; Silvestri R
    Antivir Chem Chemother; 2010 Aug; 20(6):213-37. PubMed ID: 20710063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What do docking and QSAR tell us about the design of HIV-1 reverse transcriptase nonnucleoside inhibitors?
    Paneth A; Płonka W; Paneth P
    J Mol Model; 2017 Oct; 23(11):317. PubMed ID: 29046967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.